Levofloxacino Serraclinics

Levofloxacin, the active ingredient in Levofloxacino Serraclinics, is a fluoroquinolone antibiotic presented as an intravenous formulation for injection use. It treats a range of serious bacterial infections, including pneumonia, urinary‑tract, intra‑abdominal and skin infections, in adult patients as prescribed by a qualified clinician.

GNH USA supplies Levofloxacino Serraclinics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in several organ systems. - Community‑acquired pneumonia: eradicates the typical bacterial pathogens responsible for acute lung infection. - Hospital‑acquired pneumonia: provides coverage against resistant Gram‑negative and Gram‑positive organisms. - Complicated urinary tract infections: eliminates causative bacteria in upper and lower urinary tracts. - Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic flora. - Skin and soft tissue infections: treats serious bacterial cellulitis and wound infections. - Bacterial prostatitis: penetrates prostatic tissue to clear infection.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: often self‑limiting but may be watery. - Headache: transient and usually resolves without intervention. - Dizziness: occasional sensation of light‑headedness. - Rash: non‑specific skin eruption. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, often linked to sudden activity. - QT interval prolongation: may precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis following gut flora disruption. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Peripheral neuropathy: numbness or tingling in extremities.

Levofloxacin requires careful assessment of patient‑specific factors before use. - Renal impairment: dose adjustment may be needed based on creatinine clearance. - Hepatic impairment: monitor liver function tests during therapy. - QT prolongation risk: avoid in patients with known cardiac conduction disorders. - Tendon injury risk: advise patients to refrain from excessive physical activity during treatment. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Antacid co‑administration: separate dosing by at least 2 hours to prevent absorption reduction. - Store below 25°C: keep in original container, protect from moisture and light.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Other fluoroquinolones: additive toxicity, especially tendon and CNS effects. - QT‑prolonging agents (e.g., macrolides, antiarrhythmics): increase risk of cardiac arrhythmias. - Warfarin: may potentiate anticoagulant effect, raising INR. - NSAIDs: heightened seizure risk in susceptible individuals.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use raises tendon rupture probability. - Theophylline: levofloxacin can increase serum theophylline levels. - Cyclosporine: may elevate cyclosporine concentrations. - Digoxin: monitor for possible increased serum digoxin. - Diabetic agents (e.g., insulin, sulfonylureas): risk of hypoglycemia may be enhanced.